Treatment | Children with Cancer UK

Filter by Cancer Type

Designing drugs to cut acute lymphoblastic leukaemia (ALL) at its roots

Designing drugs to cut acute lymphoblastic leukaemia (ALL) at its roots

Prof. Olaf Heidenreich, Newcastle University and the Princess Maxima Centre for Paediatric Oncology

Unravelling the world-wide survival disparities in children, teenagers and young adults with leukaemia and lymphoma

Global surveillance of survival from haematological malignancies in children, teenagers and young adults

Prof Claudia Allemani, London School of Hygiene and Tropical Medicine

Engineering the immune system to treat T-cell acute lymphoblastic leukaemia (T-ALL)

Exploiting a novel immunotherapy target for the treatment of T-cell acute lymphoblastic leukaemia (T-ALL)

Dr Marc Mansour, UCL Cancer Institute

An exploratory pilot study to enable development of improved drug therapy for childhood bone cancer

A pilot Investigation of the ZFP36L1 protein as a candidate therapeutic target in osteosarcoma cells

Dr John Murphy, University of Westminster

Improving the treatment of children with relapsed or persistent acute lymphoblastic leukaemia

Optimising the use of repurposed drugs to improve the treatment of children with ALL

Prof. Julie Irving, Newcastle University

Investigating the long-term health impacts of surviving childhood cancer

Investigating late effects of surviving childhood cancer

Dr Defne Saatci, University of Oxford

1 2 3 4 5 … 18